Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Manning Paul B
Relationship:   Director, 10% Owner
City:   Allegan
State:   MI
   
Insider Summary:
  
   
Companies Owned :   6    
Direct Shares   11,174,330    

Indirect Shares

  32,467,868      
Direct Value   $41,768,001    

Indirect Value

  $41,168,038      
Total Shares   43,642,198      
Total Value   $82,936,039      


Verrica Pharmaceuticals Inc.
 $41,768,001 Taysha Gene Therapies, Inc.
 $0 Candel Therapeutics, Inc.
 $0 Verrica Pharmaceuticals Inc.
 $41,768,001 Taysha Gene Therapies, Inc.
 $0 Candel Therapeutics, Inc.
 $0
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    10   
    0    

     Stock price went up :

    6   
    0    
     Stock price went down :
    4   
    0    
   
     Gain/Loss Ratio :
   1.5   
   0.0   
     Percentage Gain/Loss :
   28.1%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Avexis, Inc. AVXS Former 10% Owner, Dire... 2018-05-15 0 2018-05-15 0    Premium*  
            Dova Pharmaceuticals, Inc. DOVA Director, 10% Owner 2019-11-12 0 2019-11-12 0    Premium*  
            Verrica Pharmaceuticals Inc. VRCA Director, 10% Owner 2023-07-24 7,851,128 2023-07-24 7,738,353    Premium*  
            Taysha Gene Therapies, Inc. TSHA 10% Owner 2022-10-31 1,642,202 2023-11-17 23,517,778    Premium*  
            Acumen Pharmaceuticals, Inc. ABOS 10% Owner 2021-07-06 0 2021-07-06 657,985    Premium*  
            Candel Therapeutics, Inc. CADL Director, 10% Owner 2021-07-29 1,681,000 2021-07-29 553,752    Premium*  
* Premium Members only  

Records found :    25         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 1
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
TSHA Taysha Gene Therapies, In... 10% Owner   –       –       •   2023-11-17 4 B $1.63 $163,000 I/I 100,000 16,566,667 1.5 -
TSHA Taysha Gene Therapies, In... 10% Owner   –       –       •   2023-08-16 4 B $0.90 $14,820,000 I/I 16,466,667 16,466,667 1.5 -
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2023-07-24 4 B $5.02 $1,004,000 D/D 200,000 7,851,128 3.92 %
TSHA Taysha Gene Therapies, In... Director   –       •       •   2022-10-31 4 B $2.00 $3,000,000 D/D 1,500,000 1,642,202 3.92 -
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2022-07-05 4 B $2.10 $9,999,998 D/D 4,761,904 13,651,128 3.92 %
TSHA Taysha Gene Therapies, In... Director   –       •       •   2022-02-03 4 B $7.84 $208,560 I/I 26,602 2,091,704 2.25 -
TSHA Taysha Gene Therapies, In... Director   –       •       •   2022-02-03 4 B $7.84 $392,000 D/D 50,000 142,202 3.92 -
TSHA Taysha Gene Therapies, In... Director   –       •       •   2022-02-02 4 B $7.77 $520,590 I/I 67,000 22,000 2.25 -
TSHA Taysha Gene Therapies, In... Director   –       •       •   2022-02-02 4 B $7.77 $450,660 D/D 58,000 92,202 3.92 -
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2021-12-03 4 B $9.22 $184,188 D/D 19,977 8,149,394 3.92 %
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2021-12-02 4 B $9.45 $283,717 D/D 30,023 8,129,417 3.92 %
TSHA Taysha Gene Therapies, In... Director   –       •       •   2021-11-23 4 B $12.54 $250,800 D/D 20,000 32,000 3.92 -
CADL Candel Therapeutics, Inc. Director   –       •       •   2021-07-29 4/A B $8.00 $13,000,000 D/D 1,625,000 1,681,000 3.92 -
CADL Candel Therapeutics, Inc. Director   –       •      –    2021-07-29 4 A $0.00 $0 I/I 1,232,910 553,752 0 -
CADL Candel Therapeutics, Inc. Director   –       •      –    2021-07-29 4 B $7.30 $145,944 D/D 20,000 56,000 2.39 -
CADL Candel Therapeutics, Inc. Director   –       •      –    2021-07-27 4 B $7.36 $264,834 D/D 36,000 36,000 2.39 -
ABOS Acumen Pharmaceuticals, I... 10% Owner   –       –       •   2021-07-06 4 A $0.00 $0 I/I 3,608,469 657,985 0 -
ABOS Acumen Pharmaceuticals, I... 10% Owner   –       –       •   2021-07-06 4 B $16.00 $5,000,000 I/I 312,500 3,352,693 1.5 -
TSHA Taysha Gene Therapies, In... Director   –       •       •   2021-05-14 4 B $20.98 $251,760 D/D 12,000 12,000 3.92 -
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2021-03-25 4 B $14.75 $10,912,493 I/I 739,830 739,830 2.25 %
TSHA Taysha Gene Therapies, In... Director   –       •       •   2020-09-28 4 A $0.00 $0 I/I 5,295,307 2,020,102 0 -
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2020-08-20 4 B $9.09 $181,800 D/D 20,000 8,099,394 3.92 %
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2020-08-18 4 B $8.55 $85,500 I/I 10,000 1,481,719 2.25 %
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2020-08-17 4 B $6.92 $41,520 I/I 6,000 1,471,719 2.25 %
VRCA Verrica Pharmaceuticals I... Director   –       •       •   2020-08-14 4 B $6.51 $325,500 I/I 50,000 1,465,719 2.25 %

  25  Records found
  1     
  Page 1 of 1  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed